Alcohol Use Disorder and Alcohol-Associated Liver Disease.
alcohol
alcohol-associated liver disease
liver diseases
mortality
patient readmission
policy
prevention
screening
Journal
Alcohol research : current reviews
ISSN: 2169-4796
Titre abrégé: Alcohol Res
Pays: United States
ID NLM: 101594475
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
This article is part of a Festschrift commemorating the 50th anniversary of the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Established in 1970, first as part of the National Institute of Mental Health and later as an independent institute of the National Institutes of Health, NIAAA today is the world's largest funding agency for alcohol research. In addition to its own intramural research program, NIAAA supports the entire spectrum of innovative basic, translational, and clinical research to advance the diagnosis, prevention, and treatment of alcohol use disorder and alcohol-related problems. To celebrate the anniversary, NIAAA hosted a 2-day symposium, "Alcohol Across the Lifespan: 50 Years of Evidence-Based Diagnosis, Prevention, and Treatment Research," devoted to key topics within the field of alcohol research. This article is based on Dr. Shah's presentation at the event. NIAAA Director George F. Koob, Ph.D., serves as editor of the Festschrift.
Identifiants
pubmed: 36420303
doi: 10.35946/arcr.v42.1.13
pii: arcr-42-1-13
pmc: PMC9662170
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
13Déclaration de conflit d'intérêts
Disclosures Dr. Ramkissoon declares no competing financial or nonfinancial interests. Dr. Shah and Mayo Clinic have a known arrangement with Generon, the manufacturer of human recombinant IL-22. Dr. Shah does not receive any personal funding in this arrangement.
Références
World J Gastroenterol. 2013 Sep 28;19(36):5953-63
pubmed: 24106395
Curr Opin Electrochem. 2018 Aug;10:126-135
pubmed: 30859141
Cochrane Database Syst Rev. 2010 Sep 08;(9):CD004332
pubmed: 20824837
Liver Int. 2016 Apr;36(4):555-62
pubmed: 26604165
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266
pubmed: 31981519
BMJ. 2018 Jul 18;362:k2817
pubmed: 30021785
Am J Gastroenterol. 2018 Feb;113(2):175-194
pubmed: 29336434
Liver Transpl. 2020 Jan;26(1):127-140
pubmed: 31743578
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Addiction. 2017 Jul;112(7):1173-1183
pubmed: 28192622
Addict Behav. 2020 Mar;102:106128
pubmed: 31865172
Alcohol Clin Exp Res. 2021 Oct;45(10):2103-2117
pubmed: 34486129
Gastroenterology. 1978 Aug;75(2):193-9
pubmed: 352788
Alcohol Clin Exp Res. 2011 Oct;35(10):1749-58
pubmed: 21615426
Gastroenterology. 2011 Nov;141(5):1572-85
pubmed: 21920463
Clin Gastroenterol Hepatol. 2020 Feb;18(2):477-485.e5
pubmed: 31042580
N Engl J Med. 2015 Apr 23;372(17):1619-28
pubmed: 25901427
Hepatology. 2020 Aug;72(2):441-453
pubmed: 31774566
Addiction. 2004 Jul;99(7):811-28
pubmed: 15200577
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1356-1358
pubmed: 29199144
Clin Transplant. 2014 Oct;28(10):1112-20
pubmed: 25059535
J Hepatol. 2019 Feb;70(2):249-259
pubmed: 30658726
Addiction. 2020 Jun;115(6):1038-1049
pubmed: 31943464
Hepatology. 2021 May;73(5):2039-2050
pubmed: 32986883
Hepatology. 2021 Feb;73(2):571-585
pubmed: 32246544
N Engl J Med. 2013 Jan 24;368(4):365-73
pubmed: 23343065
J Gen Intern Med. 2007 Jun;22(6):822-5
pubmed: 17503108
N Engl J Med. 2018 Sep 27;379(13):1251-1261
pubmed: 30257164
Am J Gastroenterol. 2017 Feb;112(2):306-315
pubmed: 27922027
Liver Transpl. 2011 Oct;17(10):1200-4
pubmed: 21744466
N Engl J Med. 2018 Apr 05;378(14):1291-1301
pubmed: 29527973
Am J Public Health. 2010 Nov;100(11):2270-8
pubmed: 20864710
Lancet. 2007 Dec 8;370(9603):1915-22
pubmed: 18068515
Mayo Clin Proc. 2020 Dec;95(12):2612-2620
pubmed: 33276835